共 20 条
[1]
Defective angiogenesis in mice lacking endoglin. Li DY,Sorensen LK,Brooke BS,et al. Science . 1999
[2]
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. Li C,Hampson IN,Hampson L,et al. The FASEB Journal . 2000
[3]
Antiangiogenic therapy of established tumors in human skin severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Takahashi N,Haba A,Matsuno F,et al. Cancer Research . 2001
[4]
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Matsuno F,Haruta Y,Kondo M,et al. Clinical Cancer Research . 1999
[5]
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. Guerrero Esteo M,Sanchez Elsner T,Letamendia A,et al. Journal of Biological Chemistry . 2002
[6]
Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies. Tabata M,Kondo M,Haruta Y,et al. International Journal of Cancer . 1999
[7]
Angiogenesis and metastasis marker of human tumors. Seon BK,Takahashi N,HabaA,et al. Rinsho Byori . 2001
[8]
Endoglin is a suitable target for efficient imaging of solid tumors; in vivo evidence in a canine mammary carcinoma model. Fonsatti E,Jekunen AP,Kairemo KJ,et al. Clinical Cancer Research . 2000
[9]
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Lode HN,Moehler T,Xiang R,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[10]
A murine model of hereditary hemorrhagic telangiectasia. Bourdeau A,Dumont DT,Letarte M. The Journal of Clinical Investigation . 1999